Allscripts Healthcare Solutions (NASDAQ:MDRX) had its target price boosted by Raymond James from $16.00 to $17.00 in a report issued on Tuesday, ARN reports.
Shares of Allscripts Healthcare Solutions (NASDAQ:MDRX) traded down 2.04% during mid-day trading on Tuesday, hitting $14.91. Allscripts Healthcare Solutions has a 52 week low of $8.85 and a 52 week high of $16.43. The stock’s 50-day moving average is currently $15.07. The company’s market cap is $2.648 billion.
Other equities research analysts have also recently issued reports about the stock. Analysts at Robert W. Baird raised their price target on shares of Allscripts Healthcare Solutions from $16.00 to $18.00 in a research note to investors on Friday, August 9th. Separately, analysts at Thomson Reuters/Verus upgraded shares of Allscripts Healthcare Solutions from a hold rating to a buy rating in a research note to investors on Monday, July 29th. Finally, analysts at Lazard Capital Markets raised their price target on shares of Allscripts Healthcare Solutions from $12.00 to $14.00 in a research note to investors on Monday, July 15th.
One analyst has rated the stock with a sell rating, eight have issued a hold rating and six have issued a buy rating to the stock. The stock presently has a consensus rating of Hold and a consensus target price of $15.59.
Allscripts Healthcare Solutions, Inc (NASDAQ:MDRX) is a provider of clinical, financial, connectivity and information solutions and related professional services to hospitals, physicians and post-acute organizations.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.